|
|
Volumn 57, Issue 3, 1999, Pages 232-235
|
|
A phase II evaluation of clofazimine plus doxorubicin in advanced, unresectable primary hepatocellular carcinoma
|
|
Author keywords
Clofazimine doxorubicin; Hepatocellular carcinoma
|
|
Indexed keywords
CLOFAZIMINE;
DOXORUBICIN;
ADOLESCENT;
ADULT;
ADVANCED CANCER;
AGED;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LEUKOPENIA;
LIVER CELL CARCINOMA;
MALE;
MUCOSA INFLAMMATION;
NAUSEA;
ORAL DRUG ADMINISTRATION;
PIGMENT DISORDER;
PRIORITY JOURNAL;
SKIN PIGMENTATION;
VOMITING;
ADOLESCENT;
ADULT;
AGED;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, HEPATOCELLULAR;
CLOFAZIMINE;
DOXORUBICIN;
FEMALE;
HUMANS;
LIVER NEOPLASMS;
MALE;
MIDDLE AGED;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
|
EID: 0032821367
PISSN: 00302414
EISSN: None
Source Type: Journal
DOI: 10.1159/000012036 Document Type: Article |
|
Times cited : (12)
|
|
References (8)
|
